Asset Details
Do you wish to reserve the book?
Normocalcemic primary hyperparathyroidism: From pathophysiology to clinical management
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Normocalcemic primary hyperparathyroidism: From pathophysiology to clinical management
Do you wish to request the book?
Normocalcemic primary hyperparathyroidism: From pathophysiology to clinical management
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Normocalcemic primary hyperparathyroidism: From pathophysiology to clinical management
2024
Overview
Normocalcemic primary hyperparathyroidism (NPHPT), a variant of primary hyperparathyroidism (PHPT) characterized by persistently elevated parathyroid hormone (PTH) levels and normal serum calcium, has gained recognition as a substantial subset of PHPT cases. Despite its increasing prevalence, the precise pathophysiology and natural progression of NPHPT remain enigmatic. This in-depth literature review explores recent advancements in our understanding of NPHPT, encompassing pathophysiology, clinical presentation, diagnostic approaches, medical and surgical management options. By synthesizing this wealth of information, this review aims to contribute to a more nuanced and informed approach to the treatment of patients grappling with NPHPT. As our understanding of the condition continues to evolve, the knowledge gathered from this review has the potential to significantly enhance the quality of care and outcomes for individuals afflicted with NPHPT, ultimately improving their overall well-being and prognosis.
•Normocalcaemic Primary Hyperparathyroidism (NPHPT) is a Distinct Clinical Entity.•Comprehensive Review of Diagnostic Criteria and Challenges.•Outlines Therapeutic Efficacy and Decision-making.
Publisher
Elsevier Inc,Elsevier Limited
